Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
Authors
Keywords
Pancreatic cancer, Cancer stem cells, GLI transcription factor, GANT-61, mTOR, Rapamycin
Journal
Molecular Cancer
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-27
DOI
10.1186/s12943-016-0534-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
- (2015) Ulrike Graab et al. Oncotarget
- CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
- (2014) Qiang Ding et al. Molecular Cancer
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
- (2013) Mariella Gruber Filbin et al. NATURE MEDICINE
- Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts
- (2013) Patrick C. Hermann et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions
- (2013) Shyuichiro Matsubara et al. Scientific Reports
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft
- (2012) Junsheng Fu et al. CANCER LETTERS
- Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine
- (2012) Tomomi Hayashi et al. CANCER SCIENCE
- Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy
- (2012) Sonshin Takao et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer
- (2011) Qiang Ding et al. Human Cell
- Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer
- (2010) Adam Steg et al. CANCER BIOLOGY & THERAPY
- Hedgehog Signaling Drives Cellular Survival in Human Colon Carcinoma Cells
- (2010) T. Mazumdar et al. CANCER RESEARCH
- Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
- (2009) Maria–Theresa Mueller et al. GASTROENTEROLOGY
- GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
- (2009) O. Nolan-Stevaux et al. GENES & DEVELOPMENT
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started